Technical Analysis for CBAY - CymaBay Therapeutics Inc.

Grade Last Price % Change Price Change
grade C 8.93 -2.40% -0.22
CBAY closed down 2.4 percent on Friday, January 18, 2019, on 54 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical CBAY trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Support Bullish 0.00%
Jan 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Down 3 Days in a Row Weakness 0.00%
Jan 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.40%
Jan 17 Narrow Range Bar Range Contraction -2.40%
Jan 17 NR7 Range Contraction -2.40%
Jan 17 Wide Bands Range Expansion -2.40%
Jan 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.93%
Jan 16 Wide Bands Range Expansion -2.93%

Older signals for CBAY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Cymabay Therapeutics, Inc. focuses on developing therapies to treat metabolic diseases. Its lead product candidate is Arhalofenate, which completed five Phase II clinical trials for the treatment of gout. The company's product candidate also includes MBX-8025, a selective agonist that is in a Phase II clinical trial in patients with mixed dyslipidemia; and MBX-2982, an oral, G-protein coupled receptor agonist to treat type II diabetes. Cymabay Therapeutics, Inc. has a development and license agreements with Janssen Pharmaceuticals, Inc. to develop and discover undisclosed metabolic disease target agonists for the treatment of T2DM and other disorders; and a license and development agreement with DiaTex, Inc. to develop and commercialize therapeutic products. The company was formerly known as Metabolex, Inc. Cymabay Therapeutics, Inc. was incorporated in 1988 and is based in Newark, California.
Is CBAY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.59
52 Week Low 6.31
Average Volume 634,973
200-Day Moving Average 11.3443
50-Day Moving Average 8.9199
20-Day Moving Average 8.5055
10-Day Moving Average 9.458
Average True Range 0.5068
ADX 23.71
+DI 23.6299
-DI 21.6015
Chandelier Exit (Long, 3 ATRs ) 8.5996
Chandelier Exit (Short, 3 ATRs ) 7.8304
Upper Bollinger Band 10.6998
Lower Bollinger Band 6.3112
Percent B (%b) 0.6
BandWidth 51.597202
MACD Line 0.2086
MACD Signal Line 0.1298
MACD Histogram 0.0788
Fundamentals Value
Market Cap 390.74 Million
Num Shares 43.8 Million
EPS -1.07
Price-to-Earnings (P/E) Ratio -8.35
Price-to-Sales 82.44
Price-to-Book 122.03
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.47
Resistance 3 (R3) 9.50 9.35 9.38
Resistance 2 (R2) 9.35 9.21 9.34 9.35
Resistance 1 (R1) 9.14 9.13 9.07 9.11 9.32
Pivot Point 8.99 8.99 8.95 8.98 8.99
Support 1 (S1) 8.78 8.85 8.71 8.75 8.54
Support 2 (S2) 8.63 8.77 8.62 8.51
Support 3 (S3) 8.42 8.63 8.48
Support 4 (S4) 8.39